A treatment of acute myeloid leukemia being developed by Sanofi (SNY) US Services was granted FDA orphan designation, according to a post to the agency’s website. Published first on TheFly – the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback